Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer
- PMID: 20029977
- PMCID: PMC2815173
- DOI: 10.1002/cncr.24813
Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer
Abstract
Background: This study was undertaken to characterize the relation between the survival of patients with stage IIIB/IV nonsmall cell lung cancer (NSCLC) and pack-years of cigarette smoking (graded according to the American Joint Committee on Cancer staging system).
Methods: Data were analyzed from patients with stage IIIB/IV NSCLC who had completed a prospective smoking questionnaire. The impact of pack-years of cigarette smoking, age, sex, Karnofsky performance status (KPS), and the presence of weight loss >5% was evaluated on overall survival using univariate and multivariate analyses.
Results: Smoking history and clinical data were available for 2010 patients with stage IIIB/IV NSCLC (1004 women and 1006 men). Approximately 70% of patients (1409 patients) had smoked >15 pack-years, 13% (270) were former and current smokers who had smoked < or = 15 pack-years, and 16% (331) were never-smokers (<100 lifetime cigarettes). Never-smokers had a longer median survival compared with former or current smokers (17.8 months vs 11.3 months; log-rank P < .001). Among smokers, patients with a < or = 15 pack-year history of smoking had a longer median survival than patients who had smoked >15 pack-years (14.6 months vs 10.8 months; log-rank P = .03). As the number of pack-years increased, the median overall survival decreased (log-rank P < .001). Multivariate analysis indicated that a history of smoking was an independent prognostic factor (hazard ratio, 1.36; P < .001).
Conclusions: More cigarette smoking, measured in pack-years, was associated with decreased survival after a diagnosis of stage IIIB/IV NSCLC. Trials assessing survival in patients with stage IIIB/IV NSCLC should report a detailed cigarette smoking history for all patients.
Copyright 2009 American Cancer Society.
Figures
Similar articles
-
Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers.J Thorac Oncol. 2013 Jan;8(1):123-5. doi: 10.1097/JTO.0b013e31827914ea. J Thorac Oncol. 2013. PMID: 23242442 Free PMC article.
-
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.Chest. 2007 Jul;132(1):185-92. doi: 10.1378/chest.07-0442. Epub 2007 Jun 15. Chest. 2007. PMID: 17573517
-
Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer.Int J Clin Oncol. 2013 Feb;18(1):17-25. doi: 10.1007/s10147-011-0334-z. Epub 2011 Nov 10. Int J Clin Oncol. 2013. PMID: 22072116
-
Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.J Thorac Oncol. 2013 Jun;8(6):753-8. doi: 10.1097/JTO.0b013e31828b51f5. J Thorac Oncol. 2013. PMID: 23575412
-
CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study.Appl Immunohistochem Mol Morphol. 2004 Dec;12(4):315-22. doi: 10.1097/00129039-200412000-00005. Appl Immunohistochem Mol Morphol. 2004. PMID: 15536330
Cited by
-
Associations between alcohol, smoking, and cartilage composition and knee joint morphology: Data from the Osteoarthritis Initiative.Osteoarthr Cartil Open. 2019 Nov 8;1(1-2):100006. doi: 10.1016/j.ocarto.2019.100006. eCollection 2019 Nov-Dec. Osteoarthr Cartil Open. 2019. PMID: 36474720 Free PMC article.
-
Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study.Front Oncol. 2023 Jan 9;12:1092355. doi: 10.3389/fonc.2022.1092355. eCollection 2022. Front Oncol. 2023. PMID: 36698397 Free PMC article.
-
Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.Med Oncol. 2015 Jan;32(1):339. doi: 10.1007/s12032-014-0339-3. Epub 2014 Nov 28. Med Oncol. 2015. PMID: 25429831
-
Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers.J Thorac Oncol. 2013 Jan;8(1):123-5. doi: 10.1097/JTO.0b013e31827914ea. J Thorac Oncol. 2013. PMID: 23242442 Free PMC article.
-
The association between active participation in a sports club, physical activity and social network on the development of lung cancer in smokers: a case-control study.BMC Res Notes. 2012 Jan 4;5:2. doi: 10.1186/1756-0500-5-2. BMC Res Notes. 2012. PMID: 22214387 Free PMC article.
References
-
- Fujisawa T, Iizasa T, Saitoh Y, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol. 1999;17:2086–2091. - PubMed
-
- Martins SJ, Pereira JR. Clinical factors and prognosis in non-small cell lung cancer. Am J Clin Oncol. 1999;22:453–457. - PubMed
-
- Myrdal G, Lambe M, Gustafsson G, et al. Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics. Ann Thorac Surg. 2003;75:356–363. - PubMed
-
- Tan YK, Wee TC, Koh WP, et al. Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. Lung Cancer. 2003;40:237–246. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials